Form 8-K - Current report:
SEC Accession No. 0001641172-25-024477
Filing Date
2025-08-15
Accepted
2025-08-15 17:10:42
Documents
18
Period of Report
2025-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 60223
2 EX-5.1 ex5-1.htm EX-5.1 13308
3 EX-10.1 ex10-1.htm EX-10.1 224440
4 EX-10.2 ex10-2.htm EX-10.2 84980
5 EX-99.1 ex99-1.htm EX-99.1 14734
6 GRAPHIC ex5-1_001.jpg GRAPHIC 3017
  Complete submission text file 0001641172-25-024477.txt   651060

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE scnx-20250813.xsd EX-101.SCH 3017
8 XBRL LABEL FILE scnx-20250813_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE scnx-20250813_pre.xml EX-101.PRE 22360
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3567
Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)